262 related articles for article (PubMed ID: 30321526)
1. Menopausal symptoms and surgical complications after opportunistic bilateral salpingectomy, a register-based cohort study.
Collins E; Strandell A; Granåsen G; Idahl A
Am J Obstet Gynecol; 2019 Jan; 220(1):85.e1-85.e10. PubMed ID: 30321526
[TBL] [Abstract][Full Text] [Related]
2. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
[TBL] [Abstract][Full Text] [Related]
3. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.
van Lieshout LAM; Steenbeek MP; De Hullu JA; Vos MC; Houterman S; Wilkinson J; Piek JM
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012858. PubMed ID: 31456223
[TBL] [Abstract][Full Text] [Related]
4. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of prophylactic salpingectomy during vaginal hysterectomy.
Antosh DD; High R; Brown HW; Oliphant SS; Abed H; Philip N; Grimes CL
Am J Obstet Gynecol; 2017 Nov; 217(5):605.e1-605.e5. PubMed ID: 28734829
[TBL] [Abstract][Full Text] [Related]
6. Operative Outcomes of Opportunistic Bilateral Salpingectomy at the Time of Benign Hysterectomy in Low-Risk Premenopausal Women: A Systematic Review.
Kho RM; Wechter ME
J Minim Invasive Gynecol; 2017 Feb; 24(2):218-229. PubMed ID: 27988392
[TBL] [Abstract][Full Text] [Related]
7. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
Hanley GE; McAlpine JN; Pearce CL; Miller D
Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
[TBL] [Abstract][Full Text] [Related]
8. Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis.
Cadish LA; Shepherd JP; Barber EL; Ridgeway B
Am J Obstet Gynecol; 2017 Nov; 217(5):603.e1-603.e6. PubMed ID: 28619689
[TBL] [Abstract][Full Text] [Related]
9. The Use of Opportunistic Salpingectomy at the Time of Benign Hysterectomy.
Till SR; Kobernik EK; Kamdar NS; Edwards MG; As-Sanie S; Campbell DA; Morgan DM
J Minim Invasive Gynecol; 2018 Jan; 25(1):53-61. PubMed ID: 28712794
[TBL] [Abstract][Full Text] [Related]
10. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
[TBL] [Abstract][Full Text] [Related]
11. Tips and Tricks for Performing Salpingectomy at the Time of Laparoscopic Hysterectomy.
Stuparich MA; Lee TTM
J Minim Invasive Gynecol; 2017 Feb; 24(2):205. PubMed ID: 27956107
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
Venkatesh KK; Clark LH; Stamilio DM
Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer risk after salpingectomy: a nationwide population-based study.
Falconer H; Yin L; Grönberg H; Altman D
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25628372
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic supracervical hysterectomy with concomitant bilateral salpingectomy--why not?
Berlit S; Tuschy B; Kehl S; Brade J; Sütterlin M; Hornemann A
Anticancer Res; 2013 Jun; 33(6):2771-4. PubMed ID: 23749939
[TBL] [Abstract][Full Text] [Related]
16. Single-port laparoscopy in gynecologic oncology: seven years of experience at a single institution.
Moulton L; Jernigan AM; Carr C; Freeman L; Escobar PF; Michener CM
Am J Obstet Gynecol; 2017 Nov; 217(5):610.e1-610.e8. PubMed ID: 28619688
[TBL] [Abstract][Full Text] [Related]
17. Hysterectomy and opportunistic salpingectomy (HOPPSA): study protocol for a register-based randomized controlled trial.
Idahl A; Darelius A; Sundfeldt K; Pålsson M; Strandell A
Trials; 2019 Jan; 20(1):10. PubMed ID: 30611296
[TBL] [Abstract][Full Text] [Related]
18. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and Outcomes of Opportunistic Bilateral Salpingectomy in Patients with Traditional Relative Contraindications to Vaginal Hysterectomy.
Chichura AM; Yao M; Bretschneider CE; Ridgeway B; Kho RM
J Minim Invasive Gynecol; 2020; 27(6):1405-1413. PubMed ID: 31812614
[TBL] [Abstract][Full Text] [Related]
20. Mini-Laparoscopy for Removal (Partial) of Adnexae at the Time of Hysterectomy.
Setúbal AG; Alves JS; Lavado O; Faria J
J Minim Invasive Gynecol; 2017 Feb; 24(2):201-202. PubMed ID: 27856389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
